13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE Filed 2025-05-14 Event 2025-05-07 SEC 0000950170-25-071441 →

COLUMN GROUP III, LP → Tenaya Therapeutics, Inc. TNYA

Stake: 30.30% Shares: 49,313,559 CUSIP: 87990A106 Class: Common Stock, par value $0.0001 per share
Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 24/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%
  • Passive Schedule 13G filer baseline
  • High conviction ownership stake (30.3%)
  • Held by 1 tracked 13F institutional manager
  • Moderate short days-to-cover (4.6 DTC)

Item 4 — Purpose of Transaction

The information set forth in Item 4 of the Original Schedule 13D is incorporated herein by reference.

Cross-References

Insider Activity (last 365d)
10 transactions
3 buys · 7 sales · 0 awards/exercises
Issuer Cluster
6 13D/G filings on this issuer
5 other filings besides this one
Filer Track Record
3 filings by this filer
2 other filings in the data moat
Short Interest · settle 2026-10-15
DTC 4.63
22,517,147 shares short · -1.8% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $27K
Point72 Asset Mgmt

Post-Filing Returns · since 2025-05-07 on TNYA

+1 day
0.0%
+5 days
0.0%
+30 days
0.0%
+60 days
0.0%
+90 days
0.0%
+180 days
0.0%

Anchor price 0.92 on closest trading day on/after 2025-05-07. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-08-17 Ali Faraz director, officer Sale 5,837 $0.71 $4K
2026-08-17 Ali Faraz director, officer Sale 3,969 $0.71 $3K
2026-08-17 Ali Faraz director, officer Sale 5,020 $0.71 $4K
2026-08-17 Ali Faraz director, officer Sale 7,406 $0.71 $5K
2026-08-17 Tingley Whittemore officer Sale 1,637 $0.71 $1K
2026-08-17 Tingley Whittemore officer Sale 1,871 $0.71 $1K
2026-08-17 Tingley Whittemore officer Sale 2,279 $0.71 $2K
2026-05-28 Williams R Sanders director Award 120,000 $0.80 $96K
2026-05-28 Walsh Jeffrey T. director Award 120,000 $0.80 $96K
2026-05-28 Stehman-Breen Catherine director Award 120,000 $0.80 $96K

Other 13D/G Filings on Tenaya Therapeutics, Inc.

FiledFormFilerStakeShares
2026-08-24 SCHEDULE 13G INTEGRATED CORE STRATEGIES (US) LLC — — view →
2025-03-07 SCHEDULE COLUMN GROUP III, LP 32.00% 49,313,559 view →
2025-03-07 SCHEDULE Casdin Capital, LLC 4.30% 6,732,971 view →
2023-02-21 SC COLUMN GROUP III, LP — — view →
2022-11-28 SC Casdin Capital, LLC — — view →

Other Filings by COLUMN GROUP III, LP

FiledFormIssuerStakeShares
2025-03-07 SCHEDULE Tenaya Therapeutics, Inc. TNYA 32.00% 49,313,559 view →
2023-02-21 SC Tenaya Therapeutics, Inc. TNYA — — view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →